The Correlation between the Triglyceride-Glucose Index and Coagulation Markers in Patients with Recent Acute Myocardial Infarction
Table 1
Baseline demographic and risk factors.
All ()
TyG below median ()
TyG above median ()
value
Women
23 (19.7)
12 (20.7)
11 (18.9)
0.808
Age (years)
56 (10.3)
57.6 (10.8)
55.1 (10.0)
0.223
BMI (kg/m2)
28.8 (4.6)
28.1 (4.0)
29.9 (4.8)
0.013
Event
0.554
STEMI
71 (60.7)
35 (60.3)
36 (61.0)
NSTE-ACS
46 (39.3)
23 (39.7)
23 (39.0)
Arterial hypertension
86 (73.5)
44 (75.8)
42 (71.2)
0.495
Diabetes mellitus
10 (8.5)
4 (6.9)
6 (10.2)
0.093
Dyslipidaemia
75 (64.1)
37 (63.8)
38 (64.4)
0.423
Family history
46 (39.3)
24 (41.4)
22 (37.3)
0.695
Smoker
54 (46.2)
25 (43.1)
29 (49.2)
0.181
Antiplatelet drugs
0.940 0.824
ASA
116 (99.1)
58 (100)
58 (98.3)
Clopidogrel
12 (10.3)
7 (12.1)
5 (8.5)
Prasugrel
25 (21.4)
12 (20.7)
13 (22.0)
Ticagrelor
73 (62.4)
36 (62.1)
37 (62.7)
ACE inhibitor
91 (77.8)
47 (81.0)
44 (74.6)
0.615
Beta-blocker
95 (81.2)
46 (79.3)
49 (83.1)
0.580
Statins
117 (100)
58 (100)
59 (100)
0.761
Rosuvastatin
104 (88.9)
53 (91.4)
51 (86.4)
Atorvastatin
13 (11.1)
5 (8.6)
8 (13.6)
ASA: acetylsalicylic acid; BMI: body mass index; NSTE-ACS: non-ST-elevation acute coronary syndrome; SD: standard deviation; STEMI: ST-elevation myocardial infarction; TyG: triglyceride-glucose index; : results displayed as number (%); : results displayed as mean (standard deviation).
